Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis – maintenance of healing and symptom relief

Summary Background Dexlansoprazole MR, a modified‐release formulation of dexlansoprazole, an enantiomer of lansoprazole, effectively heals erosive oesophagitis. Aim To assess dexlansoprazole MR in maintaining healed erosive oesophagitis. Methods Patients (n = 451) with erosive oesophagitis healed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2009-11, Vol.30 (9), p.895-907
Hauptverfasser:	HOWDEN, C. W., LARSEN, L. M., PEREZ, M. C., PALMER, R., ATKINSON, S. N.
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects Adult Aged Anti-Ulcer Agents - administration & dosage Anti-Ulcer Agents - adverse effects Biological and medical sciences Dexlansoprazole Digestive system Dose-Response Relationship, Drug Double-Blind Method Esophagitis - drug therapy Esophagus Female Gastroenterology. Liver. Pancreas. Abdomen Heartburn - prevention & control Humans Lansoprazole Male Medical sciences Middle Aged Other diseases. Semiology Pharmacology. Drug treatments Proton Pump Inhibitors - administration & dosage Proton Pump Inhibitors - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!